MPO and glycogen storage disease VI: Finally, recently three subclasses of AAV have been proposed, based on ANCA specificity during it clinical course, and described as non-severe AAV (mainly PR3-AAV limited disease), severe PR3-AAV (with multiorgan potentially life-threatening manifestation), and severe MPO-AVV (with dominant symptoms of vasculitis and chronic organ damage) (138).